India, June 9 -- Tuesday's top biotech gainers include Regentis, which provided an update on its single-step knee repair implant; Eloxx, after getting uplisted to the Nasdaq; Alignment Healthcare, following recent corporate disclosures, including restricted stock unit (RSU) grants to executives; and Cartesian, which inked a strategic licensing deal with WestGene, among others.
Read on.
RGNT Walks the Talk
Regentis Biomaterials Ltd. (RGNT), a tissue repair company focused on developing and commercializing an innovative hydrogel platform for the repair of damaged tissue, was up over 88% on Tuesday.
The company is set to commence European Surgeon Training next quarter (Q3, 2026) for GelrinC in knee cartilage repair, as commercial launch pr...